© 2020 MJH Life Sciences and OncLive. All rights reserved.
January 23, 2020
Sandy Wong, MD, discusses the ongoing research of antibody-drug conjugates in multiple myeloma.
January 18, 2020
Sandy Wong, MD, discusses ways to mitigate the toxicities of selinexor in patients with relapsed/refractory multiple myeloma.
January 03, 2020
Sandy Wong, MD, discusses investigational CAR T-cell products in relapsed/refractory multiple myeloma.
January 18, 2019
Sandy Wong, MD, assistant professor, University of California, San Francisco (UCSF) School of Medicine, discusses an investigational antibody-drug conjugate (ADC) in multiple myeloma.